This Week in HIV Research: Stroke Risk in Less-Studied Populations
March 30, 2018
This Week in HIV Research: Stroke Risk in Less-Studied Populations
March 30, 2018
1 of 5
Next >
Welcome to our latest journey through the forest of peer-reviewed, published, HIV-related studies. This week, our travels take us down four distinct paths, showing us:
- New data on stroke risk among underrepresented HIV-positive populations, including women and African Americans.
- How a mathematical model makes us feel about the realism of achieving UNAIDS 90-90-90 goals.
- Evidence within hair follicles regarding long-term antiretroviral therapy and its effects -- or lack thereof -- on HIV persistence and inflammation.
- The predictive power of HDL cholesterol for eventual immune recovery among treatment-naive people living with HIV.
Read on for more on each of these studies. To beat HIV, you have to follow the science!
Image Credit: utah778 for iStock via Thinkstock
Welcome to our latest journey through the forest of peer-reviewed, published, HIV-related studies. This week, our travels take us down four distinct paths, showing us:
- New data on stroke risk among underrepresented HIV-positive populations, including women and African Americans.
- How a mathematical model makes us feel about the realism of achieving UNAIDS 90-90-90 goals.
- Evidence within hair follicles regarding long-term antiretroviral therapy and its effects -- or lack thereof -- on HIV persistence and inflammation.
- The predictive power of HDL cholesterol for eventual immune recovery among treatment-naive people living with HIV.
Read on for more on each of these studies. To beat HIV, you have to follow the science!
Image Credit: utah778 for iStock via Thinkstock